HELIOS Kliniken

Fatal events during clinical trials: an evaluation of deaths during breast cancer studies (2019) Furlanetto J, von Minckwitz G, Lederer B, Möbus V, Schneeweiss A, Huober J, Fasching P, et al. Journal article Pruritus bei systemischen Erkrankungen (2019) Kremer A, Mettang T Journal article, Review article Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus (2019) Untch M, Thomssen C, Bauerfeind I, Braun M, Brucker SY, Felberbaum R, Hagemann F, et al. Journal article Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc (2019) Liang R, Kagwiria R, Zehender A, Dees C, Bergmann C, Krasowska D, Michalska-Jakubus M, et al. Journal article Concerning Dediu M, Zielinski A: A Proposal to Redefine Pathologic Complete Remission as Endpoint following Neoadjuvant Chemotherapy in Early Breast Cancer. Breast Care 2019; Doi 10.1159/000500620 (2019) Untch M, Loibl S, Fasching P Journal article, Letter Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trial (2019) Schneeweiss A, Moebus V, Tesch H, Hanusch C, Denkert C, Luebbe K, Huober J, et al. Journal article Predictors for the Development of Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) - Data from the German SSc-Network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution The absolute and relative effects of presurgical nasoalveolar moulding in bilateral cleft lip and palate patients compared with nasal growth in healthy newborns (2019) Grill FD, Rau A, Bauer FX, Hellmundt F, Hilmer B, Roth M, Behr AV, et al. Journal article Therapy landscape in patients with metastatic HER2-positive breast cancer: Data from the PRAEGNANT real-world breast cancer registry (2019) Lux MP, Nabieva N, Hartkopf AD, Huober J, Volz B, Taran FA, Overkamp F, et al. Journal article Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial (2019) Janning M, Müller V, Vettorazzi E, Cubas-Cordova M, Gensch V, Ben-Batalla I, zu Eulenburg C, et al. Journal article